Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
Hisashi Saji, Morihito Okada, Masahiro Tsuboi et al. · The Lancet · 2022
Cited by 1,729 works. doi:10.1016/s0140-6736(21)02333-3
Authors
- Hisashi Saji
- Morihito Okada
- Masahiro Tsuboi
- Ryu Nakajima
- Kenji Suzuki
- Keiju Aokage
- Tadashi Aoki
- Jiro Okami
- Ichiro Yoshino
- Hiroyuki Ito
- Norihito Okumura
- Masafumi Yamaguchi
- Norihiko Ikeda
- Masashi Wakabayashi
- Kenichi Nakamura
- Haruhiko Fukuda
- Shinichiro Nakamura
- Tetsuya Mitsudomi
- Shun-ichi I. WATANABE
- Hisao Asamura
References
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
- Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer
- Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study
- Radical lobectomy
- Is segmentectomy with lymph node assessment an alternative to lobectomy for non–small cell lung cancer of 2 cm or smaller?
- A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201)
- A Phase III Randomized Trial of Lobectomy Versus Limited Resection for Small-sized Peripheral Non-small Cell Lung Cancer (JCOG0802/WJOG4607L)
- “Early” peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan
- Anatomic Segmentectomy in the Treatment of Stage I Non-Small Cell Lung Cancer
- Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis